Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more than in 2022/23.
Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October).
Two technologies, HeartLogic and TriageHF, have been recommended in final diagnostic guidance.
More evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.
NICE International has helped to adapt 3 NICE guidelines and their associated quality indicators for use in the Cypriot healthcare system.
Our annual report and accounts, which summarises our key achievements from April 2023 to March 2024.
Our contribution to world-leading research.
Dr Raja discusses the vital role frontline NHS colleagues have on our independent committees, and how you can get involved.
